Koup J R, Lau A H, Brodsky B, Slaughter R L
Antimicrob Agents Chemother. 1979 May;15(5):651-7. doi: 10.1128/AAC.15.5.651.
The apparent body clearance of chloramphenicol was investigated in 21 hospitalized adult patients on 27 occasions. Apparent body clearance was found to be significantly lower (1.99 +/- 1.49 ml/min per kg) in patients with total serum bilirubin concentrations of >1.5 mg/100 ml than in patients with serum bilirubin concentrations of </=1.5 mg/100 ml (3.57 +/- 1.72 ml/min per kg; P < 0.001). Serum protein binding of chloramphenicol was lower in cirrhotic patients (42.2 +/- 6.8% bound) than in normal adults (53.1 +/- 5.2% bound; P < 0.001). Low binding of chloramphenicol was also found in the serum of premature neonates (32.4 +/- 8.2% bound; P < 0.001). Reduced binding in neonates implies the need for a lower therapeutic range of total chloramphenicol concentration (3.5 to 13.9 mug/ml) compared with the usual adult range (5 to 20 mug/ml). Finally, three case reports are presented which demonstrate marked abnormalities and intrasubject variation in chloramphenicol clearance.
在21例住院成年患者中进行了27次氯霉素表观体内清除率的研究。发现总血清胆红素浓度>1.5mg/100ml的患者,其氯霉素表观体内清除率显著低于血清胆红素浓度≤1.5mg/100ml的患者(分别为1.99±1.49ml/min per kg和3.57±1.72ml/min per kg;P<0.001)。肝硬化患者中氯霉素的血清蛋白结合率低于正常成年人(分别为42.2±6.8%结合和53.1±5.2%结合;P<0.001)。在早产儿血清中也发现氯霉素结合率较低(32.4±8.2%结合;P<0.001)。新生儿结合率降低意味着与通常的成人范围(5至20μg/ml)相比,氯霉素总浓度的治疗范围需要更低(3.5至13.9μg/ml)。最后,给出了3例病例报告,这些报告显示了氯霉素清除率的显著异常和个体内差异。